Lumiata announced today that it has completed $14 million in Series B funding, led by Defy.vc and AllegisNL Capital along with existing investors Khosla Ventures and Blue Venture Fund.

Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we're driving predictability and precision at scale - empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights.

Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.